RI
RTW Investments Portfolio holdings
AUM
$7.02B
1-Year Est. Return
28.16%
1 Year Est. Return
+28.16%
AUM
$6.54B
AUM Growth
-$74.4M
(-1.1%)
Holding
82
Top Buys
| 1 | +$100M | |
| 2 | +$65.3M | |
| 3 | +$42M | |
| 4 |
BBNX
Beta Bionics
BBNX
|
+$40.4M |
| 5 |
uniQure
QURE
|
+$35.6M |
Top Sells
| 1 | +$145M | |
| 2 | +$132M | |
| 3 | +$40.1M | |
| 4 |
Dyne Therapeutics
DYN
|
+$36.9M |
| 5 |
Alkermes
ALKS
|
+$22.2M |
Sector Composition
| 1 | Healthcare | 99.88% |
| 2 | Financials | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Madrigal Pharmaceuticals
MDGL
$9.78B
| $660M | 10.1% |
1,993,687
|
|
||
2
argenx
ARGX
$51.9B
| $399M | 6.1% |
673,497
|
|
||
3
PTC Therapeutics
PTCT
$5.24B
| $381M | 5.83% |
7,483,127
+90,000
|
|
||
4
Natera
NTRA
$24.9B
| $367M | 5.61% |
2,593,546
+223
|
|
||
5
Axsome Therapeutics
AXSM
$6.38B
| $341M | 5.21% |
2,922,729
-1,128,636
|
|
||
6
Akero Therapeutics
AKRO
$4.32B
| $300M | 4.59% |
7,419,340
+559,517
|
|
||
7
Protagonist Therapeutics
PTGX
$4.82B
| $277M | 4.23% |
5,719,415
+220,870
|
|
||
8
Avidity Biosciences
RNA
$6.99B
| $258M | 3.95% |
8,746,926
+814,056
|
|
||
9
Penumbra
PEN
$9.71B
| $231M | 3.53% |
862,770
+320
|
|
||
10
Insmed
INSM
$35B
| $230M | 3.52% |
3,014,558
|
|
||
|
11
Alkermes
ALKS
$5B
| $227M | 3.48% |
6,884,698
-673,137
|
|
||
12
Stryker
SYK
$143B
| $220M | 3.36% |
590,221
|
|
||
|
VRNA
13
DELISTED
Verona Pharma
VRNA
| $181M | 2.77% |
2,848,800
+1,027,781
|
|
||
14
Merus
MRUS
$7.19B
| $175M | 2.68% |
4,169,393
|
|
||
15
Tarsus Pharmaceuticals
TARS
$3.08B
| $170M | 2.61% |
3,316,032
+79,483
|
|
||
16
Immunocore
IMCR
$1.69B
| $144M | 2.21% |
4,869,798
|
|
||
17
Acadia Pharmaceuticals
ACAD
$3.52B
| $142M | 2.17% |
8,540,117
-165,384
|
|
||
18
Rocket Pharmaceuticals
RCKT
$400M
| $118M | 1.8% |
17,687,772
|
|
||
19
RadNet
RDNT
$5.92B
| $115M | 1.76% |
2,317,582
+339,000
|
|
||
20
Masimo
MASI
$7.97B
| $114M | 1.74% |
683,294
|
|
||
21
Zai Lab
ZLAB
$3.15B
| $113M | 1.73% |
3,136,680
+627,561
|
|
||
22
Cytokinetics
CYTK
$6.99B
| $109M | 1.67% |
2,721,158
|
|
||
23
Establishment Labs
ESTA
$1.37B
| $105M | 1.61% |
2,583,887
+14,200
|
|
||
24
Apogee Therapeutics
APGE
$3.73B
| $101M | 1.55% |
2,712,097
|
|
||
25
Intuitive Surgical
ISRG
$160B
| $100M | 1.53% |
+202,456
|
|